This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Acco Brands (ACCO) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Acco (ACCO) delivered earnings and revenue surprises of -22.22% and -2.73%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Berry Global (BERY) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Berry Global's (BERY) second-quarter fiscal 2020 revenues increase 52.6% year over year on account of impressive performance across the Consumer Packaging segment.
ITT Q1 Earnings & Revenues Surpass Estimates, Decline Y/Y
by Zacks Equity Research
ITT's first-quarter 2020 revenues decrease 4.6% year over year on account of lackluster performance across most of the segments.
Pick These 3 Winning Stocks Based on a Favorable P/B Ratio
by Kinjel Shah
Though price-to-earnings and price-to-sales are the first choices, P/B ratio is also a convenient tool for identifying valuable stocks.
Honeywell (HON) Q1 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Honeywell's (HON) first-quarter 2020 revenues decline 5% year over year on account of lackluster performance across most of its segments.
Fortune Brands (FBHS) Q1 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Fortune Brands' (FBHS) first-quarter 2020 revenues increase 6% year over year on account of impressive performance across all of its segments.
Tetra Tech (TTEK) Q2 Earnings Surpass Estimates, Rise Y/Y
by Zacks Equity Research
Tetra Tech's (TTEK) Q2 earnings rise 4.3% year over year on sales growth.
ABB Q1 Earnings and Revenues Decline Y/Y, Orders Decrease
by Zacks Equity Research
ABB's Q1 revenues fall year over year on weak performance across its segments.
Is Acco Brands (ACCO) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Crane (CR) Q1 Earnings and Revenues Miss Estimates, Down Y/Y
by Zacks Equity Research
Crane's (CR) first-quarter 2020 revenues decline 4.1% year over year on lackluster performance across its segments.
Roper (ROP) Earnings Surpass Estimates in Q1, Decline Y/Y
by Zacks Equity Research
Roper's (ROP) first-quarter 2020 revenues improve 5% year over year on impressive performance across its Application Software, and Network Software & Systems segments.
Acco Brands (ACCO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Acco (ACCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Barnes (B) Earnings and Revenues Surpass Estimates in Q1
by Zacks Equity Research
Barnes' (B) first-quarter 2020 revenues decline 12.2% year over year on lackluster performance across its segments.
IDEX (IEX) Q1 Earnings & Revenues Beat Estimates, Decline Y/Y
by Zacks Equity Research
IDEX's (IEX) first-quarter 2020 revenues decline 4.5% year over year on account of lackluster performance across all of its segments.
Tetra Tech (TTEK) Wins $90M Contract From U.S. Air Force
by Zacks Equity Research
Tetra Tech (TTEK) gains from contracts received from government agencies. The technical support services contract from the U.S. Air Force will likely boost the company's business in Africa and Europe.
Allegion (ALLE) Q1 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Allegion's (ALLE) first-quarter 2020 revenues improve 3% year over year on account of impressive operational performance in the Americas region.
Carlisle (CSL) Q1 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Carlisle's (CSL) first-quarter 2020 revenues decline 3.9% year over year on account of lackluster performance across its CIT, CFT and CBF segments, owing to the coronavirus outbreak.
Emerson (EMR) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Emerson's (EMR) second-quarter fiscal 2020 revenues decline 9% year over year on decreased demand, particularly in March, owing to the coronavirus outbreak.
Roper (ROP) to Benefit From Acquisitions Despite Headwinds
by Zacks Equity Research
Roper (ROP) is likely to benefit from strength across its network software and medical products businesses, and acquired assets. However, high debt and operating expenses are concerning.
Yes, You Can Time the Market. Find out How - April 17, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
6 Valuable Price-to-Book Stocks to Buy as Recession Lurks
by Kinjel Shah
Though price-to-earnings and price-to-sales are the first choices, P/B ratio is also a convenient tool for identifying valuable stocks.
Allegion (ALLE) Withdraws Annual View on Coronavirus Concerns
by Zacks Equity Research
Allegion (ALLE) withdraws guidance for 2020, owing to uncertainties in the end-markets on the impacts of the coronavirus outbreak.
Is Acco Brands (ACCO) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Enerpac Highlights Business Actions Amid Coronavirus Concern
by Zacks Equity Research
Enerpac (EPAC) highlights several actions to maintain a healthy capital structure amid the coronavirus outbreak.
Why Hold Strategy is Apt for Avery Dennison Stock Right Now
by Zacks Equity Research
Given its focus on pricing action, restructuring activities and stellar growth projections, Avery Dennison (AVY) stock is worth retaining in the portfolio at the moment.